Notice of Intent to Sole Source to Werfen USA LLC for the lease of two ACL Top 750 Systems
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) intends to award a firm fixed-price purchase order to Werfen USA LLC for the lease of two ACL Top 750 Systems. This is a Notice of Intent to Sole Source, not a request for proposals. The purpose is to continue the lease for systems currently used in the Hematology Service section at the Department of Laboratory Medicine. Capability statements are due by March 11, 2026.
Scope of Work
The requirement is for the continued lease of two ACL Top 750 systems (Product Number 00000280015). These analyzers provide cutting-edge automation and quality management for routine and specialized coagulation tests, designed for mid to high-volume clinical laboratories. They feature automated pre-analytical sample-integrity checks, advanced quality/accreditation support, and enhanced system security, utilizing clotting, chromogenic, and immunological methodologies.
Contract & Timeline
- Type: Firm Fixed-Price Purchase Order (Notice of Intent to Sole Source)
- Duration: One year, from March 12, 2026, to March 11, 2027
- Set-Aside: None (Sole Source)
- Response Due: March 11, 2026, 12:00 PM EST
- Published: March 4, 2026
- Place of Performance: Bethesda, MD 20892 USA
- Estimated Value: Not to exceed the Simplified Acquisition Threshold ($250,000.00)
Justification & Response
This acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, specifically Subpart 13.106-1(b)(1), as Werfen USA LLC is identified as the sole manufacturer of consumable items for the existing ACL Top analyzers, with no other known vendor capable of meeting the requirement. Interested parties may identify their interest and capabilities in response to this notice. The government's decision not to compete is at its discretion.
Additional Notes
This is NOT a request for quotation or proposal. Only capability statements should be submitted. Submissions should be sent electronically to Shasheshe Goolsby (shasheshe.goolsby@nih.gov), referencing the posting number.